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Introduction
Bisphenol A (BPA) is a high production 
volume chemical used in a variety of com-
mon consumer products. Most notably, 
BPA is present in poly  carbonate plastics, the 
epoxy resin liners of aluminum cans, and 
thermal receipts (Ehrlich et al. 2014). BPA 
is an endocrine-disrupting chemi  cal that 
can act through a variety of physiological 
receptors, such as genomic estrogen recep-
tors 1 and 2, membrane-bound estrogen 
receptors, androgen receptor, peroxisome 
proliferator–activated receptor γ, and thyroid 
hormone receptor (reviewed by Richter 
et al. 2007).
To address research gaps in the published 
BPA studies, in 2006, an organized com-
mittee sponsored by the National Institute 
of Environmental Health Sciences (NIEHS), 
National Institute of Dental Craniofacial 
Research (NIDCR), U.S. Environmental 
Protection Agency (EPA), and Commonweal 
reviewed the associations between BPA expo-
sure and reproductive health outcomes and 
published their analyses in 2007 (vom Saal 
et al. 2007). This committee was organized 
into five topic-driven panels that evaluated 
the available data and developed guidelines 
for the conduct of future in vivo and in vitro 
studies that would facilitate comparisons 
across studies and extrapolations to human 
health outcomes. Overall, the panels recom-
mended the use of oral and dietary exposure 
routes, doses of BPA similar to human expo-
sure levels, and further evalua  tions of BPA 
concentrations in animal and human tissues 
and fluids with the aim of using doses that 
would result in human-relevant serum con-
centrations of unconjugated BPA in studies 
with experi  mental animals.
With respect to reproductive effects, the 
sub panel  evaluating  in vivo animal studies 
found contradictory results among studies 
but concluded that, based on the avail-
able evidence, a) they were confident that 
BPA impacts the male reproductive system, 
and b) they thought it likely—although it 
required confirmation—that both develop-
mental and adult exposure affect the female 
reproductive system (Richter et al. 2007). At 
the time, the prostate was the most exten-
sively studied reproductive tissue, with both 
develop  mental and adult exposures reported 
to increase prostate size [reviewed by Richter 
et al. (2007) and vom Saal et al. (2007)]. 
However, not all studies reported effects, 
and controversy remained regarding the 
doses necessary to elicit effects. In females, 
effects on the oocyte, developing reproductive 
tract, and timing of sexual maturation were 
available, but many remained largely uncon-
firmed [reviewed by Richter et al. (2007) and 
vom Saal et al. (2007)]. Little epidemiologi-
cal information was available, and the few 
published studies were limited in their design, 
restricting the strength of the conclusions that 
could be drawn about the reproductive haz-
ards of BPA exposure [reviewed by Richter 
et al. (2007) and vom Saal et al. (2007)]. 
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Background: In 2007, an expert panel reviewed associations between bisphenol A (BPA) exposure 
and reproductive health outcomes. Since then, new studies have been conducted on the impact of 
BPA on reproduction.
oBjective: In this review, we summarize data obtained since 2007, focusing on a) findings from 
human and animal studies, b) the effects of BPA on a variety of reproductive end points, and 
c) mechanisms of BPA action.
Methods: We reviewed the literature published from 2007 to 2013 using a PubMed search based 
on keywords related to BPA and male and female reproduction.
discussion: Because BPA has been reported to affect the onset of meiosis in both animal and 
in vitro models, interfere with germ cell nest breakdown in animal models, accelerate follicle 
transition in several animal species, alter steroido  genesis in multiple animal models and women, 
and reduce oocyte quality in animal models and women under  going in vitro fertilization (IVF), 
we consider it an ovarian toxicant. In addition, strong evidence suggests that BPA is a uterine 
toxicant because it impaired uterine endo  metrial proliferation, decreased uterine receptivity, and 
increased implantation failure in animal models. BPA exposure may be associated with adverse 
birth outcomes, hyper  androgenism, sexual dysfunction, and impaired implantation in humans, but 
additional studies are required to confirm these associations. Studies also suggest that BPA may be 
a testicular toxicant in animal models, but the data in humans are equivocal. Finally, insufficient 
evidence exists regarding effects of BPA on the oviduct, the placenta, and pubertal development.
conclusion: Based on reports that BPA impacts female reproduction and has the potential 
to affect male reproductive systems in humans and animals, we conclude that BPA is a 
reproductive toxicant.
citation: Peretz J, Vrooman L, Ricke WA, Hunt PA, Ehrlich S, Hauser R, Padmanabhan V, 
Taylor HS, Swan SH, VandeVoort CA, Flaws JA. 2014. Bisphenol A and reproductive health: update 
of experimental and human evidence, 2007–2013. Environ Health Perspect 122:775–786; http://
dx.doi.org/10.1289/ehp.1307728Peretz et al.
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Between 2007 and 2013, new studies on 
the impact of BPA on the reproductive sys-
tem have been conducted and are summa-
rized in this review. Specifically, we focus on 
summarizing a) reproductive findings from 
human studies and how they compare with 
animal studies; b) detailed information about 
the experimental effects of BPA on a vari-
ety of reproductive end points, taking into 
account species, dose, route of exposure, and 
timing of exposure; and c) mechanisms of 
BPA action in the reproductive system, when-
ever possible. Thus, this update is a compila-
tion of the more recent literature detailing 
the effects of BPA exposure on the female and 
male reproductive systems. We hope that the 
insights and conclusions of this review will be 
used to direct future studies and be used in 
developing consensus statements about the 
effects of BPA on the reproductive system 
based on the state of the evidence. 
Methods
Search strategy. We searched Pubmed 
(http://www.ncbi.nlm.nih.gov/pubmed) to 
identify journal articles published between 
2007 and 2013 that were related to BPA 
and reproduction. Search terms included 
the following:
Ovary, follicle, oocyte, oocyte competence, 
meiosis, granulosa cell, theca cell, ovulation, 
oviduct, uterus, endometrial, stroma, implanta-
tion, pregnancy, miscarriage, spontaneous abor-
tion, embryo, blastocyst, placenta, trophoblast, 
cyto tropho blast,  syncytio tropho blast,  birth, 
birth weight, gestation, transgeneration, testes, 
sperm, Leydig cell, Sertoli cell, germ cell, epididy-
mis, prostate, ventral lobe, dorsal lobe, ejacula-
tion, fertilization, infertility, sexual dysfunction, 
estradiol, testosterone, androstenedione, estrone, 
dihydro testosterone,  dehydro epi androsterone,  or 
pregnenolone. 
After the aforementioned search, we searched 
the terms “bisphenol A” and “BPA” to iden-
tify any papers that did not include the other 
selected search terms or term variants.
Article inclusion criteria. Journal articles 
found using the search terms and in the 
selected time frame were considered for 
inclusion. All human and experimental ani-
mal in vivo studies were included. In vitro 
studies were included if there was a clear 
mechanism for an effect or if the studies sup-
ported in vivo or human findings. Journal 
articles were not omitted due to a paucity of 
research in any category.
Dose designation. Similar to the 2007 
expert panel (vom Saal et al. 2007) and 
to Vandenberg et al. (2013), we defined 
“low dose” as a BPA dose of ≤ 50 mg/kg/day. 
This is the currently accepted lowest adverse 
effect level (LOAEL) used by the U.S. 
EPA (U.S. EPA 1993). Thus, “high-dose” 
BPA studies are those using concentrations 
> 50 mg/kg/day. Throughout the text, we 
use the terms “low dose” and “high dose” 
to provide a simple description of the 
doses used in each study. However, specific 
doses used in each study are listed in the 
Supplemental Material.
Exposure timing. Here, we define BPA 
exposure as gestational when it occurred 
in utero, neonatal when it took place after 
birth but before weaning, and post  natal when 
it occurred any time after weaning. 
Article strength determination. Similar 
to the 2007 expert panel, we considered the 
evidence to be strong when multiple studies 
in multiple species indicated a similar effect 
of BPA on a reproductive tissue or end point, 
even if concordance was not 100% across all 
studies, given that species and strain differ-
ences can lead to differences in dose response 
and magnitude of effect. We considered the 
evidence to be limited when some studies—
but not the majority—indicated a similar 
effect of BPA on a reproductive tissue or 
end point, and/or when data from in vitro, 
in vivo animal, and human studies were 
discordant. Finally, we considered the evi-
dence to be inconclusive when a limited num-
ber of studies had examined the effect of BPA 
on a selected reproductive tissue or end point, 
and/or when the studies were conducted in 
only one species or by in vitro studies alone. 
We recog  nize that in vitro studies have played 
critical roles in identifying how BPA affects 
specific tissues; however, because it is difficult 
to correlate human and animal health out-
comes with in vitro outcomes alone, studies 
performed in vitro only were classified as 
inconclusive. 
Early Oogenesis and Ovarian 
Follicle Formation
All included studies on BPA exposure and early 
oogenesis and follicle formation were con-
ducted using animal models or in vitro systems. 
These studies indicate that develop  mental 
BPA exposure has the potential to affect two 
stages of oogenesis: a) the onset of meiosis in 
the fetal ovary, and b) germ cell nest break-
down and follicle formation (see Supplemental 
Material, Table S1). Several reports have con-
firmed the original findings from studies in 
mice (reviewed by Richter et al. 2007) that 
gestational exposure affects the onset of meiosis 
and induces non  disjunction in meiosis in the 
fetal ovary, but does not induce aneuploidy. 
In a macaque study designed to mimic serum 
levels of unconjugated BPA reported in human 
biomonitoring studies (Vandenberg et al. 
2010), Hunt et al. (2012) observed that daily 
low-dose BPA exposure (measured < 1 ng/mL 
in maternal serum) significantly disrupted syn-
apsis and recombination between homolo-
gous chromosomes at the onset of meiosis, 
which was consistent with previous findings 
(Susiarjo et al. 2007). Three studies reported 
that gestational low-dose BPA exposure of 
mice induced changes in gene expression in 
germ cells and early meiocytes. BPA expo-
sure increased expression of Stra8 (stimulated 
by retinoic acid 8 homolog) and a variety of 
meiotic genes in C57BL/6 mice (Lawson et al. 
2011). However, longer gestational BPA expo-
sure down-regulated the expression of Stra8, 
Dazl (deleted in azoospermia-like), and Nobox 
(newborn ovary homeobox) in CD-1 mice 
(Zhang XF et al. 2012). Last, BPA exposure 
commencing after the onset of meiosis induced 
a meiotic delay at gestational day (GD) 17.5 
in CD-1 females (Zhang HQ et al. 2012). 
Collectively, these studies provide strong evi-
dence that BPA exposure disrupts meiosis in 
mice and macaques, and alters gene expres-
sion in germ cells and early meiocytes in two 
different strains of mice.
In vitro studies provide further evidence 
that BPA affects the onset of meiosis. Brieño-
Enriquez et al. (2011, 2012) reported that 
BPA (1–30 μM) increased oocyte degenera-
tion by impairing meiotic progression in cul-
tured human fetal oocytes and that, similar 
to mouse studies, human fetal oocytes that 
progressed to prophase exhibited increased 
levels of recombination (MLH1 foci) and 
gene expression changes. BPA also increased 
methylation errors in differentially methyl-
ated regions of maternally imprinted genes 
of oocytes in cultured preantral follicles of 
C57/BL6xCBA/Ca mice (Trapphoff et al. 
2013). Thus, the data from different mouse 
strains, macaques, and in vitro studies con-
sistently provide strong evidence to conclude 
that BPA exposure has detrimental effects 
on the meiotic process, both at the gene 
expression and phenotypic levels.
Studies have also suggested that BPA inter-
feres with germ cell nest breakdown in animal 
models. In neonatally exposed lambs, low-dose 
BPA was reported to increase the incidence 
of multi  oocyte follicles (Rivera et al. 2011). 
Similarly, in gestationally exposed macaques, 
dietary low-dose BPA exposure increased the 
number of oocytes present in secondary and 
antral follicles at birth, and continuous BPA 
exposure (measured < 1 ng/mL in maternal 
serum) increased the incidence of unenclosed 
oocytes (Hunt et al. 2012). Further, in gesta-
tionally exposed CD-1 mice, low-dose BPA 
increased the number of unenclosed oocytes, 
whereas it decreased the number of primor-
dial follicles in a dose-dependent manner 
(Zhang HQ et al. 2012). In another study, 
Veiga-Lopez et al. (2013) reported that pre-
natal BPA exposure altered the fetal ovar-
ian steroido  genic gene and microRNA 
expression that mediate gonadal differentia-
tion and folliculo  genesis in sheep. Collectively, 
these studies provide strong evidence that 
gestational BPA exposure—across multiple 
exposure routes, doses, and species—impairs BPA and reproductive health
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proper germ cell nest breakdown, leading to 
the formation of multi  oocyte follicles. The 
presence of multi  oocyte follicles is of concern 
because they are considered a pathologic con-
dition that may lead to ovulatory problems 
(Iguchi et al. 1990).
BPA exposure also appears to accelerate 
follicle transition and growth in several species. 
Rivera et al. (2011) reported that neonatal 
BPA exposure accelerated follicle transition 
in lambs, decreasing numbers of primordial 
follicles and increasing primary follicles with-
out affecting total follicle numbers. A similar 
enhanced activation of follicular recruitment 
was observed by Rodríguez et al. (2010) in 
neonatally exposed Wistar rats. BPA exposure 
also increased cell prolifera  tion, indicative 
of follicular growth, in small antral follicles 
in neonatally exposed lambs and Wistar rats 
(Rivera et al. 2011; Rodríguez et al. 2010). 
Taken together, the data suggest that BPA 
enhances the recruitment and growth of pri-
mordial and primary follicles across species. 
Combined with the effects on germ cell nest 
breakdown, there is strong evidence that BPA 
induces ovo  toxicity by acting on develop-
ing and immature follicle stages in animals 
models. However, the consequences of these 
effects on reproductive potential and longevity 
are unclear. In one study, low-dose neonatal 
BPA exposure decreased numbers of all fol-
licle types and increased atretic follicles in rats 
during adulthood (Li et al. 2014). These effects 
of BPA on follicles could lead to premature 
reproductive senescence, but this needs to be 
confirmed in future studies.
In vitro studies on the effects of BPA 
have focused on mature ovarian follicles. In 
murine pre  antral follicles, BPA (0.003 μM) 
accelerated development to antral follicles 
(Trapphoff et al. 2013). In murine antral 
follicles, exposure to BPA (440 μM) aber-
rantly up-regulated expression of cell cycle 
regulators and the pro  atretic and anti  atretic 
factors Bax (BCL2-associated X protein), 
Trp53 (tumor protein 53), and Bcl2 (B-cell 
lymphoma 2), inhibiting follicle growth 
and inducing apoptosis (Peretz et al. 2012). 
Further, BPA (110–440 μM) inhibited 
antral follicle growth in mice (Ziv-Gal et al. 
2013). These studies suggest that low-dose 
BPA exposure may alter follicle formation, 
but high-dose BPA may directly inhibit 
growth, cause atresia, and induce changes in 
gene expression in rodent antral follicles. In 
future studies, it will be important to vali-
date findings from these in vitro studies at 
the in vivo level and determine the conse-
quences of BPA-induced follicle toxicity on 
reproduction function.
Steroidogenesis in Females
Multiple studies have investigated the 
association between BPA exposure and ovarian 
steroid hormone production in women 
(see Supplemental Material, Table S2). In 
three publications based on women under-
going in vitro fertilization (IVF), BPA expo-
sure was associated with a decrease in peak 
serum estradiol levels prior to oocyte retrieval 
(Bloom et al. 2011a; Ehrlich et al. 2012a; 
Mok-Lin et al. 2010). A case–control study 
by Kandaraki et al. (2011) showed that BPA 
was associated with increased testosterone and 
androstenedione levels in women with poly-
cystic ovary syndrome (PCOS). In a study 
of 60 women under  going IVF, Ehrlich et al. 
(2013) found that urinary BPA concentra-
tions were not associated with a negative 
linear dose–response in the expression of the 
steroido genic  enzyme  Cyp19 in granulosa 
cells collected at the time of oocyte retrieval, 
but instead were associated with a suggested 
non  monotonic dose–response. Conversely, 
BPA was not associated with estradiol or tes-
tosterone levels in women in the INChianti 
study, a prospective, population-based study 
of adults living in Chianti, Italy (Galloway 
et al. 2010). Given the limited information 
on BPA exposure and ovarian steroido  genesis 
in women and the discrepant study results, 
additional studies utilizing sensitive and reli-
able steroid hormone and BPA assays are 
required to delineate whether BPA levels nega-
tively impact reproductive hormonal patterns 
in women. Further, given that most existing 
studies on BPA exposure and steroid levels 
were conducted in IVF populations, it is criti-
cal to examine the association between BPA 
exposure and steroido  genesis in women from 
the general population.
Several experimental studies have exam-
ined the effect of BPA exposure on ovarian 
steroido  genesis in laboratory animals (see 
Supplemental Material, Table S1). In three 
rodent studies, peri  natal (Xi et al. 2011) and 
post  natal (Fernández et al. 2010; Tan et al. 
2013) low-dose BPA exposure was reported 
to increase serum estradiol levels. Further, in 
one study of Sprague-Dawley (SD) rats and 
one of pregnant ICR mice, low-dose BPA 
increased testosterone and progesterone levels 
(Fernández et al. 2010; Tan et al. 2013). 
Interestingly, Xi et al. (2011) reported that 
post  natal BPA exposure alone did not affect 
serum hormone levels in the mice. Similarly, 
in other studies using rats, mice, and lambs, 
gestational or gestational plus neonatal BPA 
exposure had no effect on steroido  genesis 
(Kobayashi et al. 2012; Mendoza-Rodríguez 
et al. 2011; Rivera et al. 2011; Varayoud 
et al. 2011). In these four studies, the doses 
used were lower than those in studies report-
ing BPA effects, indicating that BPA doses 
< 20 mg/kg may not increase hormone 
production in animal models. In contrast, 
another study (Berger et al. 2008) found 
that although BPA did not alter estradiol 
levels, low-dose BPA decreased progesterone 
levels in adult mice during early pregnancy. 
In addition, in adult rats, low-dose BPA 
(< 0.1 mg/kg/day) decreased estradiol, testos-
terone, Cyp19 (aromatase), and Star (steroido-
genic acute regu  latory protein) (Lee SG et al. 
2013). Further, in adult mice, low-dose BPA 
decreased expression of estrogen and proges-
terone receptors but did not alter hormone 
levels (Berger et al. 2010). The differences in 
study results may be a function of exposure 
times, internal doses of BPA, or species.
The results of in vitro studies on the 
effects of BPA on steroido  genesis are also 
equivocal. BPA exposure (44 and 440 μM) 
inhibited estradiol, testosterone, androstene-
dione, estrone, dehydro  epiandrosterone, 
and progesterone production and decreased 
StAR and Cyp11a1 (cytochrome P450 side-
chain cleavage) expression in cultured intact 
murine antral follicles (Peretz et al. 2011; 
Ziv-Gal et al. 2013). However, in isolated 
rat theca-interstitial cells, BPA (0.1–100 μM) 
had opposite effects, increasing testosterone 
synthesis and Cyp17a (cytochrome P450 
17α-hydroxylase/lyase), Cyp11a1, and StAR 
expression (Zhou et al. 2008). In isolated 
rat granulosa cells, BPA (100 μM) decreased 
progesterone synthesis and increased StAR 
expression (Zhou et al. 2008). In a separate 
study using porcine granulosa cells, 0.1 μM 
BPA increased estradiol levels, whereas higher 
doses (1 and 10 μM) decreased estradiol levels. 
All three concentrations of BPA resulted in 
decreased progesterone levels (Grasselli et al. 
2010). Collectively, these studies indicate that 
BPA adversely affects steroido  genesis in vitro 
(with the effects dependent on BPA concen-
tration) and that BPA’s effects on steroido-
genesis vary by whether intact follicles or 
isolated cells are used in the cultures.
Oocytes: Quantity, Quality, 
and Fertilization
A few human studies have analyzed the 
association between urinary BPA levels and 
oocyte yield, maturation, and fertilization 
(see Supplemental Material, Table S2). In a 
small prospective study of 58 infertile women 
and 37 male partners under  going intra-
cytoplasmic sperm injection or conventional 
IVF, Fujimoto et al. (2011) found an asso-
ciation between serum BPA concentrations 
and oocyte maturation only among Asian 
women, but an overall correlation between 
increasing serum concentrations and the 
develop  mental potential of human oocytes. In 
two publications from the same prospective 
cohort of 84 women (Mok-Lin et al. 2010) 
and 174 women (Ehrlich et al. 2012a) under-
going IVF, increasing urinary BPA concentra-
tion was associated with decreased numbers 
of retrieved oocytes, mature oocytes (MII), 
and normally fertilized oocytes (2PN). These Peretz et al.
778  volume 122 | number 8 | August 2014  •  Environmental Health Perspectives
results suggest that BPA is associated with 
impaired oocyte yield, maturation, and fer-
tilization, adversely affecting the success of 
IVF treatment.
Several recent experimental results support 
the findings from earlier studies that sug-
gested BPA exposure affects the resumption of 
meiosis in the peri  ovulatory oocyte (reviewed 
by vom Saal et al. 2007) (see Supplemental 
Material, Table S1). Chao et al. (2012) 
reported that neonatal exposure to low-dose 
BPA inhibited germinal vesicle breakdown 
(GVBD) in CD-1 F1 hybrid female mice, 
confirming the previous work of Hunt et al. 
(2003). Conversely, low-dose BPA adminis-
tered to MF-1 (C57BL/6 × CBA/Ca F1 
hybrid) mice on post  natal days 22–28 did not 
reduce GVBD or polar body extrusion nor did 
it increase spindle aberrations (Eichenlaub-
Ritter et al. 2008). Similarly, low-dose BPA 
given orally to 4- or 9-week-old super  ovulated 
female C57Bl/6 mice did not affect oocyte 
retrieval, meiotic maturation, or induce aneu-
ploidy (Pacchierotti et al. 2008). Although 
the exact reasons for the subtle discrepancies 
among studies are unknown, there are numer-
ous possible reasons for the variations in the 
window of neo  natal exposure (reviewed by 
Hunt et al. 2009) and potential coexposure 
to phyto  estrogens that may modu  late the 
effects of BPA on the peri  ovulatory oocyte 
(Muhlhauser et al. 2009).
In in vitro studies, BPA (43.8 μM) has 
been reported to significantly alter spindle for-
mation, distribution of peri  centriolar mate-
rial at spindle poles, and induce congression 
failure in MF-1 mouse oocytes isolated from 
antral follicles (Eichenlaub-Ritter et al. 2008). 
In a study in follicle-enclosed oocytes from 
adult mice, Lenie et al. (2008) reported that 
BPA (30 μM) impaired spindle alignment 
and caused meiotic arrest after GVBD but 
before polar body extrusion. Importantly, a 
recent study of human oocytes exposed dur-
ing in vitro maturation, with doses of BPA 
within the range measured in human follicular 
fluid (0.02, 0.2, and 20 μg/mL), found a dose-
dependent increase in the incidence of meiotic 
arrest, disturbances in spindle formation and 
chromosome alignment, and spontaneous 
oocyte activation (Machtinger et al. 2013). 
Because the doses used were in the range mea-
sured in human follicular fluid, these data, 
together with the results of experimental 
studies, provide compelling evidence that BPA 
adversely affects the maturing oocyte.
Polycystic Ovary Syndrome 
(PCOS)
Studies on the effects of BPA on PCOS 
are limited (see Supplemental Material, 
Table S2). Women with PCOS are charac-
terized by oligo-anovulation, functional 
hyper androgenism,  and  multi follicular 
ovaries (accumulation of several small-sized 
antral follicles), with the majority of women 
showing insulin resistance and excess lutein-
izing hormone (Hampton 2013). One case–
control study of 71 women with PCOS and 
100 women without PCOS (Kandaraki et al. 
2011) showed an association between serum 
BPA levels and increased testosterone, andro-
stenedione, and insulin resistance in PCOS 
(Kandaraki et al. 2011) (see Supplemental 
Material, Table S2). Given the limited 
number of studies assessing the association 
between BPA exposure and PCOS symptoms, 
more studies are needed in order to make 
firm conclusions about the impact of BPA 
exposure on PCOS or PCOS symptoms.
The ovarian phenotype in BPA-treated 
rodents (cystic-appearing follicles) differs from 
the ovarian phenotype of women with PCOS 
(accumulation of small antral follicles). In 
rodents, pre  natal and neo  natal exposure to 
low-dose BPA lead to disruption of estrous 
cyclicity (Adewale et al. 2009), increased tes-
tosterone production (Fernández et al. 2010), 
and ovarian cysts (Newbold et al. 2009) (see 
Supplemental Material, Table S1). High-
dose BPA exposure in rodents also leads to 
ovarian cysts (Fernández et al. 2010) and an 
accumulation of large antral follicles (Adewale 
et al. 2009). In addition, Fernández et al. 
(2010) reported that BPA exposure decreased 
gonadotropin-releasing hormone (GnRH) 
levels measured from hypothalamic explants 
in vitro. Additional studies in other ani-
mal models are needed to fully understand 
whether BPA exposure causes PCOS or 
PCOS-like conditions, and to determine why 
outcomes differ in animal models and women.
Oviduct
Only one study we reviewed investigated 
the effects of BPA on the oviduct (see 
Supplemental Material, Table S1). Newbold 
et al. (2009) observed progressive proliferative 
lesions in the oviducts of adult CD-1 mice 
prenatally exposed to low-dose BPA. Because 
alterations in oviduct morphology would 
be expected to adversely affect both fertili-
zation and embryo transport, future studies 
are clearly warranted to examine the impact 
of BPA not only on the oviduct but also on 
fertilization and embryo transport.
Uterine Morphology
No studies have reported the impact of gesta-
tional BPA exposure on uterine morphology 
in women because of the extreme difficulty 
of monitoring adult outcomes of prenatal 
exposure to BPA; however, animal studies 
suggest that gestational BPA exposure per-
turbs gross morphology of the uterus in the 
adult (see Supplemental Material, Table S3). 
Specifically, low-dose BPA exposure has been 
reported to induce benign and malignant 
lesions (Newbold et al. 2009; Signorile 
et al. 2010) and endometrial polyps in the 
uterus (Newbold et al. 2009) and to per-
turb Wölffian duct regression in pre  natally 
exposed adult mice (Newbold et al. 2009). 
Further, adult hens that were exposed in ovo 
on day 4 of incubation to BPA (134 ng/kg) 
had decreased thickness of their tunica mucosa 
and density of uterine glandular structures 
compared with unexposed hens (Yigit and 
Daglioglu 2010). Together, these studies indi-
cate that gestational BPA exposure may be 
potentially deleterious to uterine morphology 
in adult females. Because abnormalities have 
been identified in middle age that were not 
observed in young adult mice (Newbold et al. 
2009), future studies should assess effects in 
exposed animals at different life stages.
Uterine Endometrium
Limited data exist on BPA exposure and 
uterine endometrium in women. One case–
control study of 69 women (Cobellis et al. 
2009) suggests that serum BPA concentra-
tions may be associated with the occurrence 
of endometriosis (see Supplemental Material, 
Table S2). In another study of 495 individu-
als in an operative cohort and 131 women 
in population cohort, Buck Louis et al. 
(2013) found no association between BPA 
exposure and endometriosis. However, that 
study was not originally intended to inves-
tigate BPA exposure, nor was it was appro-
priately powered to assess endometriosis; 
that study also included a lapse between 
sample collection and endometriosis evalua-
tion, further confounding these data. Given 
the lack of studies on BPA and endome-
trial dis  orders in humans, more studies are 
required before making conclusions about 
whether BPA adversely impacts the uterine 
endometrium in women.
Experimental studies support the findings 
of Cobellis et al. (2009) (see Supplemental 
Material, Table S3). Signorile et al. (2010) 
reported that adult female Balb-c mice 
exposed pre  natally and neo  natally to low-dose 
BPA developed endometrial-like structures 
with both glands and stroma in adipose tissue 
surrounding the genital tract. These struc-
tures expressed Hoxa10 (homeobox A10), a 
transcription factor that mediates prolifera-
tion of stromal tissue prior to implantation. 
Two other studies reported that BPA, at both 
low- and high doses, increased expression of 
Hoxa10 in prenatally exposed adult CD-1 
and ICR mice (Bromer et al. 2010; Hiyama 
et al. 2011). 
Other in vivo studies have provided 
evidence that BPA impairs proliferation in 
the uterus. In rodents, BPA exposure over 
a wide range of doses, times, and routes 
decreased expression of uterine Esr1 (estro-
gen receptor α), which may lead to inhibited BPA and reproductive health
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endometrial proliferation in the uterine 
epithelium and stroma (Berger et al. 2010; 
Bosquiazzo et al. 2010; Bromer et al. 2010; 
Varayoud et al. 2008). In two separate studies 
of adult rats, pre  natal and neo  natal exposure 
to low-dose BPA decreased uterine epithe-
lium proliferation in response to hormone 
treatments (Mendoza-Rodríguez et al. 2011; 
Varayoud et al. 2008). In a study in non-
human primates, Aldad et al. (2011) reported 
that although low-dose BPA did not affect 
progesterone receptor expression, it damp-
ened glandular and stromal progesterone 
receptor expression in response to estradiol 
stimulus. Low-dose BPA was also reported 
to impair apoptosis of the uterine epithelium 
during estrus in neo  natally exposed adult rats 
(Mendoza-Rodríguez et al. 2011).
In vitro studies also support the hypothe  sis 
that BPA exposure adversely affects the uterus. 
BPA (50 or 100 μM) has been reported to 
significantly decrease proliferation of human 
endometrial stromal fibroblasts cultured for 
48 hr (Aghajanova and Giudice 2011). BPA 
(50 μM) was also found to decrease the prolif-
eration of cultured human endometrial endo-
thelial cells (Bredhult et al. 2009). Further, in 
cultured primary hetero  geneous populations 
of uterine cells, BPA (10 μM) significantly 
inhibited uterine cell contractions, increased 
oxytocin-related pathways, and decreased 
prostaglandin-related signaling after 48 hr (An 
et al. 2013). Taken together, the existing ani-
mal and in vitro studies provide strong support 
that BPA impairs uterine cell proliferation.
Uterine Receptivity and 
Implantation
Only one study has reported on the associa-
tion between BPA exposure and uterine 
receptivity/implantation in women (see 
Supplemental Material, Table S2). In a study 
of 137 women under  going IVF, Ehrlich 
et al. (2012b) found that higher quartiles of 
urinary BPA concentrations were associated 
with increased odds of implantation failure. 
Given the limited information on this topic, 
future studies need to be conducted to deter-
mine whether BPA exposure is associated 
with adverse uterine receptivity/implantation 
outcomes in women.
Several experimental studies indicate 
that BPA exposure impairs uterine recep-
tivity and implantation (see Supplemental 
Material, Table S3). Repeated exposure 
of pregnant mice to low-dose BPA during 
early gestation was reported to completely 
ablate embryo implantation (Berger et al. 
2008; Xiao et al. 2011). A single exposure 
to high-dose BPA on GD0 or GD1, but not 
on GD2, was found to decrease implanta-
tion in mice (Berger et al. 2008, 2010). 
Neonatal exposure to low-dose BPA also 
decreased implantation sites in pregnant rats 
(Varayoud et al. 2011). Interestingly, low-
dose BPA has been reported to increase pre-
implantation loss in unexposed female rats 
mated to neo  natally exposed males (Salian 
et al. 2009a) and decrease implantation sites 
in females mated to adult exposed male rats 
(Tiwari and Vanage 2013). Further, when 
untreated and healthy embryos were trans-
planted into the uteri of low-dose-BPA–
exposed mice, implantation failed (Xiao et al. 
2011). Together, these studies provide strong 
evidence that BPA exposure, in both males 
and females, affects uterine receptivity in 
females. However, a need still exists to explore 
whether BPA-exposed embryos attach to the 
uterine epithelium and initiate implantation.
Neonatal exposure to low-dose BPA was 
also reported to decrease pregnancy mainte-
nance in experimental studies (Varayoud et al. 
2011). Low-dose BPA increased resorption 
rates in uteri of unexposed female rats mated 
to males that were neonatally exposed (Salian 
et al. 2009a), gestationally plus neo  natally 
exposed (Salian et al. 2009b), or exposed as 
adults (Tiwari and Vanage 2013), suggest-
ing that male exposure can significantly con-
tribute to pregnancy loss. These effects were 
also found in F1 and F2 offspring (Salian et al. 
2009a, 2009b), suggesting trans  genera  tional 
effects of BPA. The potential ability of BPA 
to cause transgenerational effects in animal 
models is further supported by Hiyama et al. 
(2011), who observed reduced uterine weight 
and expanded uterine lumen in mice develop-
mentally exposed to high-dose BPA, as well 
as demethylation of the Hoxa10 gene in the 
F2 generation. Collectively, these experi-
ments indicate that BPA exposure adversely 
affects implantation and pregnancy main-
tenance in animal models, which may be 
trans  generational in nature.
Embryo Development
Few studies have examined the effects of 
parental BPA levels on subsequent in vitro 
embryo development in humans (see 
Supplemental Material, Table S2). In one 
prospective preconception cohort study of 
174 women, total urinary BPA concentra-
tion was associated with a decreased rate of 
blasto  cyst formation (Ehrlich et al. 2012a). 
Further, a prospective cohort study involving 
27 couples under  going IVF treatment found 
that increasing urinary BPA concentrations 
in the male—but not the female partner—
was associated with decreased odds of a high 
embryo fragmentation score, suggesting that 
the embryos were low quality for IVF treat-
ments (Bloom et al. 2011b). Collectively, 
these studies indicate adverse associations of 
parental BPA levels on the development of 
early embryos in vitro, but further studies are 
required to determine whether the observed 
effects occur in vivo.
Although only two experimental studies 
have investigated the effects of BPA expo-
sure on early embryo development in vivo, 
the results are intriguing. Xiao et al. (2011) 
reported delayed embryo develop  ment 
in pregnant C57BL/6 mice administered 
high-dose BPA from GD0.5 to 3.5 (see 
Supplemental Material, Table S3). A more 
recent study of F1 female C57BL/6 Cast7 
mice showed that low-dose BPA exposure 
initiated prior to breeding and continuing 
through pregnancy disrupted the expression 
of imprinted genes in mid  gestation embryos 
and placentas (Susiarjo et al. 2013). Given 
the limited number of studies on the effects 
of BPA on embryo development in vivo, addi-
tional studies are needed in order to make 
firm conclusions about the effects of BPA on 
early embryos.
Placenta
Although epidemiological studies on BPA 
and the placenta have not been published, 
one experimental study Tan et al. (2013) sug-
gested that both low and high doses of BPA 
increase levels of plasma estradiol, testosterone, 
and corticotropin-releasing hormone due to 
an increase in mRNA expression of cortico-
trophin-releasing hormone and activation of 
protein kinase C ζ/λ and δ in the placenta 
(see Supplemental Material, Table S3). A few 
in vitro studies have indicated that BPA affects 
placental cell proliferation. After 24 hr or 48 hr 
of culture, BPA (1–10 μM) increased apoptosis 
and decreased prolifera  tion of cultured human 
trophoblast cells from first trimester placentas, 
whereas 10-μM BPA decreased cell viability 
(Morice at al. 2011). Similarly, after 24 hr, 
BPA (0.0877–8.77 μM) increased apoptosis in 
cultured human cyto  tropho  blasts (Benachour 
and Aris 2009). In addition, recent data from 
mouse studies suggest that BPA alters gene 
expression in the placenta (Susiarjo et al. 
2013). Taken together, these in vitro data sug-
gest that BPA may affect placental function, 
but additional animal and human studies are 
required to substantiate these data.
Pregnancy Outcomes
Only one study has examined the associa-
tion between BPA exposure and pregnancy 
outcome in humans. Specifically, in a nested 
case–control study of 60 pregnant women, 
Cantonwine et al. (2010) found a positive 
association between urinary BPA concentra-
tion and pre  term birth (see Supplemental 
Material, Table S4). Given the limited infor-
mation available, more studies are needed 
before making conclusions about whether 
BPA exposure is associated with adverse 
pregnancy outcomes in humans. 
In contrast, several experimental studies 
have investigated the effects of BPA exposure 
on pregnancy outcomes in animal models, Peretz et al.
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such as mice and rats, which are altrical species 
in which pups are born at a stage of develop-
ment equivalent to mid  gestation in humans. 
As shown in Supplemental Material, Table S5, 
several studies have reported that low-dose 
BPA did not alter gestation length in gestation-
ally plus neo  natally exposed mice (Cabaton 
et al. 2011; Kobayashi et al. 2010), adult-
exposed mice (Tyl et al. 2008), or gesta  tionally 
plus neo  natally exposed SD rats (Kobayashi 
et al. 2012). Cabaton et al. (2011) reported 
that low-dose BPA decreased the number of 
pregnancies and successful deliveries in gesta-
tionally exposed mice. BPA also decreased the 
percent of hatchings of chickens exposed in ovo 
to BPA (134 ng/kg) on day 4 on incubation 
(Yigit and Daglioglu 2010). Conversely, nei-
ther low- nor high-dose BPA affected the num-
ber of litters born to unexposed female SD rats 
mated to gestationally exposed males (Thuillier 
et al. 2009), suggesting that maternal, but not 
paternal, BPA exposure may influence success-
ful delivery of offspring.
Many experimental studies have reported 
that low-dose BPA does not affect the num-
ber of live pups (Howdeshell et al. 2008; 
Kobayashi et al. 2010, 2012; Thuillier et al. 
2009; Xi et al. 2011) or total number of 
delivered pups (Kobayashi et al. 2010, 2012; 
Nanjappa et al. 2012; Ryan et al. 2010; Tyl 
et al. 2008; Xi et al. 2011) in mice and rats. 
In a few studies, however, low-dose BPA 
exposure was reported to decrease the num-
ber of live pups born to prenatally plus neo-
natally exposed CD-1 mice (Cabaton et al. 
2011) and Holtzman rats (Salian et al. 2009b). 
Low-dose BPA also decreased the total number 
of pups born to gestationally and neonatally 
exposed CD-1 mice (Cabaton et al. 2011). 
Interestingly, BPA acted differently from the 
positive control (diethylstilbestrol; DES), sug-
gesting that the effects of BPA may differ from 
those of DES in CD-1 mice. Low-dose BPA 
also decreased the total number of pups born 
to unexposed female Holtzman rats mated to 
neonatally and gestationally exposed males of 
the same strain (Salian et al. 2009a, 2009b). In 
these two studies, BPA exposure decreased pup 
numbers after multiple litters, similar to DES. 
Collectively, these studies suggest that BPA 
exposure affects pregnancy outcomes in many, 
but not all, studies depending on experi  mental 
protocol. Clearly, more studies are required 
to determine why results differ and to deter-
mine whether BPA exposure does indeed affect 
pregnancy outcomes in animal models.
Birth Weight
Human studies of BPA and birth weight 
are equivocal (see Supplemental Material, 
Table S4). In a cross-sectional study of 
97 pregnant women, Chou et al. (2011) 
observed that women with serum BPA con-
centrations > 2.51 ng/mL had a higher risk 
for having male babies that were small for 
gestational age than did women with lower 
serum BPA concentrations. However, these 
authors found no associations with female 
babies (see Supplemental Material, Table S4). 
These results are consistent with a retrospec-
tive cohort study that included 587 births in 
which maternal and paternal occupational 
exposure to BPA were both associated with 
low birth weight and small gestational size; the 
association was stronger for maternal exposure 
than paternal exposure (Miao et al. 2011b). 
Further, in a Dutch population-based pro-
spective cohort study of 219 pregnant women, 
urinary BPA was positively associated with 
lower growth rates and smaller head circum-
ference (Snijder et al. 2013). Similarly, in a 
birth cohort study of 757 Korean pregnant 
women participating in the Mothers and 
Children’s Environmental Health (MOCEH) 
study, BPA was associated with increased 
birth weight in males and neonatal length in 
females (Lee BE et al. 2014). However, in a 
case–control study of 191 pregnant women, 
BPA had an inverse U-shaped association with 
birth weight (Philippat et al. 2012). In a cross-
sectional study of 40 pregnant women, urinary 
BPA levels at delivery were not associated with 
birth weights of the offspring (Padmanabhan 
et al. 2008). Further, in a prospective cohort 
study of 404 mother–infant pairs, BPA expo-
sure was not associated with increased birth 
weight (Wolff et al. 2008b). Given some of 
these discrepant results, future studies should 
assess whether BPA exposure is associated with 
birth weight.
In previous work, gestational exposure 
to low doses of BPA did not alter the birth 
weight of mice or rats. However, recent 
animal studies suggest that the effect of BPA 
on offspring birth weight is dose dependent 
(see Supplemental Material, Table S5). Tyl 
et al. (2008) reported that high-dose BPA 
increased the weight of offspring born to 
gesta  tionally exposed mice. Conversely, low-
dose BPA decreased the weight of offspring 
born to neonatally exposed mice (Nah et al. 
2011). However, at doses below the U.S. EPA 
reference dose (50 μg/kg) (U.S. EPA 1993), 
BPA did not affect the weight of offspring 
born to gestationally plus neo  natally 
exposed mice (Kobayashi et al. 2010) or rats 
(Howdeshell et al. 2008; Kobayashi et al. 
2012; Nanjappa et al. 2012; Ryan et al. 
2010), suggesting that BPA has a specific dose 
effect on birth weight of offspring.
Sperm Production and Quality
Human studies of the effect of adult exposure 
to BPA on sperm quality are very limited (see 
Supplemental Material, Table S6). Studies 
of occupationally exposed men (Li et al. 
2011) and men recruited from an infertil-
ity clinic (Meeker et al. 2010a) reported that 
higher urinary BPA levels were associated 
with a decrease in sperm count and motility. 
However, in a study of fertile men, urinary 
BPA concentration was not associated with 
changes in any semen parameters, but uri-
nary BPA levels were significantly associated 
with markers of free testosterone (Mendiola 
et al. 2010). Although the results of these 
few epidemiological studies are consistent, 
there is insufficient evidence to draw conclu-
sions about the association between BPA and 
semen quality in humans. 
The earliest experimental studies of the 
effects of BPA on sperm suggested adverse 
effects on spermato  genesis in the adult follow-
ing either pre  natal or early post  natal exposure 
(reviewed by Richter et al. 2007). Subsequent 
experimental studies have provided further 
evidence that prenatal and early post  natal 
exposure to BPA adversely affect spermato-
genesis and have provided new evidence that 
exposure in adult rodents affects sperm qual-
ity (see Supplemental Material, Table S7). 
In rodents, exposure during the time of tes-
tis development—either during gestation or 
in the early post  natal period—or to young 
adult males has been associated with a range 
of adverse effects in the adult testis. However, 
variability in exposure timing, species and 
strains, end points, and life stage makes a 
simple analysis of the data difficult. Despite 
the variation in study design, several findings 
have emerged repeatedly, including decreased 
sperm counts, increased apoptotic cells within 
the semi  niferous tubules, and decreased 
sperm motility; alterations in hormone levels 
and/or steroido  genic enzymes; and evidence 
of sperm DNA damage. 
The evidence that BPA exposure adversely 
affects sperm production and quality in the 
adult rodent is supported by data from recent 
studies (see Supplemental Material, Table S7). 
Gestational exposure to low-dose BPA 
resulted in a decreased number of elongated 
spermatids present in semi  niferous tubules 
in pubertal ICR mice (Okada and Kai 2008) 
and decreased sperm counts in Holtzman rats 
(Salian et al. 2009a). Similarly, both low- and 
high-dose BPA exposure during early post  natal 
development or around the time of puberty 
increased apoptosis and/or decreased spermato-
genesis in male mice and rats (Li et al. 2009; 
Liu et al. 2013; Qiu et al. 2013; Wang et al. 
2010). Further, adult rats exposed to low-dose 
BPA for either 6 or 14 days showed increased 
apoptosis and decreased sperm counts (Jin 
et al. 2013; Tiwari and Vanage 2013). 
In addition, a number of studies using vari-
ous routes of exposure (oral and sub  cutaneous) 
and different exposure times (embryonic, fetal, 
perinatal, and adult) have reported that low-
dose BPA impairs sperm motility in rats and 
mice (Dobrzynska and Radzikowska 2013; 
Minamiyama et al. 2010; Salian et al. 2009a; BPA and reproductive health
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Tainaka et al. 2012; Tiwari and Vanage 
2013) (see Supplemental Material, Table S7). 
Interestingly, Minamiyama et al. (2010) 
reported that the BPA-induced decrease in rat 
sperm motility was prevented by coadminis-
tration of the antioxidant n-acetyl cysteine, 
suggesting that impaired sperm motility may 
be related to increases in reactive oxygen spe-
cies (ROS). As reviewed by Ross et al. (2010), 
antioxidant use has been suggested to increase 
sperm quality in men and increase pregnancy 
rates of infertile couples. 
Spermatogenesis is dependent upon 
androgens, and changes that impact the 
endocrine environment of the testes have the 
potential to adversely affect sperm production 
and quality. Endocrine-related changes have 
been reported in several experimental studies: 
Rodent studies of gestational exposure alone 
and continuous gestational–neonatal exposure 
to BPA have reported evidence of impaired 
steroido  genesis, a decreased number of steroid 
receptors, or a decrease in Star expression (see 
Supplemental Material, Table S7). However, 
the most compelling data have come from 
studies of male rats exposed in the postnatal/
adult period: Most of these studies reported a 
decrease in testosterone levels and/or steroido-
genic enzymes in BPA-exposed males (low or 
high dose) compared with controls (Castro 
et al. 2013; D’Cruz et al. 2012a; El-Beshbishy 
et al. 2012; Jin et al. 2013; Nakamura et al. 
2010; Wu et al. 2011). Only one study in 
ICR mice reported no change in testosterone 
levels in low-dose-BPA–exposed males com-
pared with controls, despite the fact that the 
exposed males had impaired spermatogenesis 
(Okada and Kai 2008).
In addition to endocrine changes, sperm 
DNA damage has been reported in BPA-
exposed rodents (see Supplemental Material, 
Table S7). Consistent with studies before 
2007 (Chitra et al. 2003; Kabuto et al. 2003, 
2004), recent studies have shown that con-
tinuous exposure to low-dose BPA exposure 
induces DNA breaks and the production of 
ROS in mice and rats (Anjum et al. 2011; 
Dobrzynska and Radzikowska 2013; Fang 
et al. 2013; Liu et al. 2013; Minamiyama et al. 
2010; Rashid et al. 2009; Wu et al. 2013) (see 
Supplemental Material, Table S7). Tiwari and 
Vanage (2013) reported that oral exposure to 
low-dose BPA for 6 days also induced sperm 
DNA damage. Similarly, oral low-dose BPA 
exposure has been reported to decrease tes-
ticular glucose levels and the expression and 
translation of glucose transporter-8 in sper-
matocytes and spermatids and to increase tes-
ticular hydrogen peroxide levels in Wistar rats 
(D’Cruz et al. 2012a, 2012b) and oxidative 
stress in SD rats (Qiu et al. 2013). 
Unfortunately, the relevance of the doses 
used in the experimental studies to human 
exposure is not certain because internal or 
serum BPA levels were not determined in the 
studies. Nevertheless, these data add to the 
evidence that BPA exposure in the adult rodent 
adversely impacts the testis and sperm qual-
ity at levels below the LOAEL of 50 mg/kg. 
Although similar reproductive effects have 
been reported in multiple studies, a few studies 
failed to find any adverse reproductive effects 
in rodent models after gestational plus neo-
natal BPA exposure (Howdeshell et al. 2008; 
Kobayashi et al. 2010; LaRocca et al. 2011; 
Tyl et al. 2008) (see Supplemental Material, 
Table S7). These discordant findings may be 
related to a variety of factors, including dose, 
exposure route, internal dose, timing, and 
selected end points. Nevertheless, common-
alities among studies finding no adverse effects 
raise several concerns. First, two of the four 
studies used the same inbred mouse strain, 
C57BL/6 (LaRocca et al. 2011; Kobayashi 
et al. 2010), suggesting that this strain may 
be insensitive or less sensitive to the effects 
of BPA on sperm than other strains. Second, 
dietary exposure has been used in several 
no-effect studies, but it was not used in any 
studies reporting adverse effects. These results 
add to the concern about the role that route 
of exposure plays in BPA studies and sub-
stantiates calls to replace exposure route with 
measurements of internal dose. Indeed, recent 
studies have shown that the route of BPA 
adminis  tration results in markedly different 
ratios of unconjugated (bioactive) to conju-
gated BPA and provided evidence that much 
of human exposure must be from non-oral 
routes (Gayrard et al. 2013; vom Saal et al. 
2014). Last, two of the studies (Howdeshell 
et al. 2008; Tyl et al. 2008) focused on 
end points such as body/organ weight, which 
alone may not accurately measure effects on 
male fertility. Indeed, some studies reporting 
detrimental effects (e.g., increased germ cell 
apoptosis, reduction in sperm counts) did not 
find significant changes in testis or epididymal 
weight (see Supplemental Material, Table S7). 
Nevertheless, these negative findings under-
score the need for comparative experimental 
studies involving different strains of animals 
and routes of exposure. In addition, assess-
ing the importance of effects during different 
life stages is important, particularly because 
Newbold et al. (2009) identified abnormali-
ties in middle age that were not seen in young 
adult female rodents.
Steroidogenesis in Males
Three epidemiological studies investigated the 
association between BPA exposure and serum 
hormone levels in men (see Supplemental 
Material, Table S6). In a study of 307 Italian 
men participating in the INChianti study (a 
prospective, population-based study of adults 
living in Chianti, Italy), Galloway et al. (2010) 
observed an association between increased 
urinary BPA concentrations and increased 
serum testosterone levels, but not estradiol 
levels. This observation was not supported 
by two cross-sectional studies of 167 and 
302 fertile men, which reported no correla-
tion between BPA exposure and testosterone 
levels (Meeker et al. 2010b; Mendiola et al. 
2010). However, Mendiola et al. (2010) 
found associations between urinary BPA 
concentrations and decreased free androgen 
index (FAI), the ratio of FAI to luteinizing 
hormone, and the ratio of free testosterone 
to luteinizing hormone in male partners of 
pregnant women. Meeker et al. (2010b) found 
an association between high BPA concentra-
tions and increased serum levels of follicle-
stimulating hormone, and between high 
BPA concentrations and decreased levels of 
inhibin B, the ratio of follicle-stimulating hor-
mone to inhibin B, and the ratio of estradiol 
to testosterone. These data suggest that BPA 
can alter steroid hormone pathways in men; 
however, because of limited association studies 
and likely multi  factorial responses produced 
by BPA, more studies are needed to determine 
how BPA affects steroidogenesis. Further, 
because most studies conducted before 2007 
focused on infertile men, it is important to 
conduct studies on fertile men to confidently 
determine if BPA affects male steroidogenesis 
and whether findings in infertile men can be 
extrapolated to the general population.
Experimental studies indicate that BPA 
exposure decreases hormone levels in male 
animals, but the data are discordant (see 
Supplemental Material, Table S7). Low-dose 
BPA was reported to decrease testosterone 
levels in gestationally through postnatally 
exposed CD-1 mice (Xi et al. 2011) but not 
in adult C57BL/6 mice exposed in utero 
(LaRocca et al. 2011). Low-dose BPA 
decreased testosterone levels in gestationally 
or neonatally exposed Holtzman rats (Salian 
et al. 2009a, 2009b), adult-exposed albino 
rats (El Beshbishy et al. 2012), and adult-
exposed Wistar rats (D’Cruz et al. 2012a). 
Conversely, gestational plus neonatal exposure 
to low-dose BPA did not affect testosterone 
levels in Long Evans (LE) rats (Howdeshell 
et al. 2008) or SD rats (Kobayashi et al. 2012; 
Qiu et al. 2013). However, although Sánchez 
et al. (2013) reported that low dose BPA did 
not decrease testosterone in Wistar rats, low-
dose BPA decreased dihydrotestosterone levels 
(Sánchez et al. 2013). Mechanistic under-
pinnings for the ability of BPA to inhibit tes-
tosterone levels may be found in the fact that 
BPA decreases expression of steroido  genic 
enzymes (Horstman et al. 2012; Nakamura 
et al. 2010; Qiu et al. 2013; Xi et al. 2011) 
and levels of follicle-stimulating hormone, 
which are required to directly and indirectly 
stimulate steroido  genesis (Salian et al. 2009a, 
2009b). Collectively, these data indicate that Peretz et al.
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BPA exposure decreases sex steroid hormone 
levels in male rodents, but strain and species, 
as well as other confounders (e.g., time, route 
of exposure, age at analysis), may modulate 
the sensitivity to BPA effects.
Because Leydig cells are responsible for 
most steroid hormone production in males, 
experimental studies have been designed to 
examine whether BPA directly affects Leydig 
cells. In pubertal Wistar/ST rats, continu-
ous exposure to high-dose BPA was reported 
to decrease cell numbers and expression of 
steroidogenic enzymes in the Leydig cells. 
(Nakamura et al. 2010). Conversely, low-
dose BPA increased Leydig cell numbers in 
gestationally plus neo  natally exposed LE rats 
in adulthood by up-regulating mitogenic fac-
tors (Nanjappa et al. 2012). Although BPA 
exposure increased Leydig cell proliferation, it 
did not alter circulating testosterone levels. In 
fact, in in vitro Leydig cell isolates from adult-
exposed males, low-dose BPA decreased the 
expression of steroido  genic enzymes and tes-
tosterone production (Nanjappa et al. 2012). 
Similarly, BPA decreased testos  terone levels 
in human, mouse, and rat fetal testes in vitro 
(N’Tumba-Byn et al. 2013). In another 
study, Thuillier et al. (2009) reported that 
gestational exposure to low- and high-dose 
BPA increased Leydig cell numbers without 
affecting serum testosterone levels in SD 
rats in adulthood. Collectively, these data 
strongly suggest that BPA negatively affects 
gonadal function through changes in steroid-
synthesizing cells/enzymes, which then affect 
steroid synthesis and circulating steroid levels.
Anogenital Distance and 
Cryptorchidism
Disruptions in testicular testosterone 
production during development may lead to 
pheno  typic abnormalities after birth, such 
as shortened anogenital distance (AGD) and 
undescended testes. In a retrospective occu-
pational study of 587 Chinese children, Miao 
(2011b) found a dose-dependent associa  tion 
between parental occupational exposure to 
BPA and shortened AGD in male offspring 
(see Supplemental Material, Table S4). This 
inverse correlation was strengthened with 
increasing maternal BPA concentrations 
(Miao et al. 2011a). Interestingly, Fenichel 
et al. (2012) observed that BPA concentra-
tions in cord blood samples were not cor-
related with cryptorchidism in a matched 
case–control study of 152 newborn males. 
Although these studies suggest that BPA 
exposure may be associated with shortened 
AGD and undescended testes, it is impor-
tant to confirm these findings in other 
epidemiological studies.
In several animal studies, BPA exposure 
did not affect AGD, but it did influence 
testes descent (see Supplemental Material, 
Table S7). In four recent studies, gestational 
or gestational plus neonatal exposure to 
low-dose BPA did not alter AGD in male 
rodents (Howdeshell et al. 2008; Kobayashi 
et al. 2010, 2012; LaRocca et al. 2011). In 
another study, Tyl et al. (2008) reported 
that gestational exposure to high-dose BPA 
decreased absolute AGD in F1 CD-1 males 
at birth, but not in the F2 generation and 
not when normalized to relative body size. 
In the same study, high-dose BPA delayed 
preputial separation and increased the inci-
dence of treatment-related undescended 
testes in F1 and F2 offspring. Notably, the 
doses used by Tyl et al. (2008) were very high 
and not physiologically relevant to human 
exposure. Collectively, these data suggest that 
BPA exposure may not affect AGD in animal 
models, but it may affect other developmental 
aspects such as undescended testes.
Male Urinary Tract
To date, no epidemiological studies have 
reported associations between BPA exposure 
and alterations in the male urinary tract, and 
only a few experimental studies have evalu-
ated the effects of BPA on the male urinary 
tract (see Supplemental Material, Table S7). 
In the adult rat prostate, low- and high-dose 
BPA exposure has been reported to adversely 
increase clusterin levels and expression of aro-
matase, while decreasing levels of 5α-reductase 
type 1 and 2 (Castro et al. 2013; De Flora 
et al. 2011; Sánchez et al. 2013). Interestingly, 
Castro et al. (2013) and De Flora et al. (2011) 
reported that BPA exposure increased the 
plasma estradiol to testosterone ratio, which 
has been implicated in the development of 
benign prostate hyper  plasia (Nicholson et al. 
2012; Nicholson and Ricke 2011). Further, 
gestational exposure to low-dose BPA increased 
gene expression of androgen receptor, Esr1, 
aromatase, and estrogen-related receptor γ in 
the mouse prostate (Arase et al. 2011). 
Other studies have indicated that BPA 
exposure plays a role in prostate patho  genesis 
in animal models. Prins et al. (2011) reported 
that neonatal exposure of rats to low-dose 
BPA increased the incidence of the precur-
sor for prostate cancer, prostate intra  epithelial 
neoplasia, in adulthood. Further, Wu et al. 
(2011) reported that in rats with induced 
prostatic hyperplasia, high-dose BPA increased 
prostate gland mass and increased relative 
weight of the dorso  lateral prostate lobe. High-
dose BPA exposure also increased epithelial 
cell heights in the ventral prostate and dorso-
lateral prostate lobes (Wu et al. 2011). Last, 
neonatal exposure to low-dose BPA led to 
transient and permanent hypo  methylations in 
the rat epi  genome, implicated in the manifes-
tation of prostatic carcino  genesis (Tang et al. 
2012). Collectively, these studies support the 
concept that both low and high doses of BPA 
promote changes in steroido  genic pathways 
and morphology of the prostate, which may in 
turn affect homeo  stasis and pathogenesis.
Currently, no information is available 
about whether BPA exposure causes benign 
urologic disease. However, studies have 
shown that estrogens and estrogen receptor 
pathways negatively affect the lower urinary 
tract (Nicholson et al. 2012; Ricke et al. 
2008; Wang et al. 2007; Willingham and 
Baskin 2007), supporting a potential role for 
  estrogen-like molecules, including BPA, in the 
manifestation of urological diseases. Future 
experimental studies evaluating the effects 
of BPA on the lower urinary tract, as well as 
epidemiological studies in humans, need to 
gain insight into the role BPA plays in disease 
processes in the lower male urinary tract.
Puberty and Sexual Receptivity
Two epidemiological studies investigated the 
effect of BPA on puberty and measured BPA 
levels in girls at similar ages (see Supplemental 
Material, Table S2). In these studies, one of 
1,151 girls 6–8 years of age (Wolff et al. 2010) 
and another of 192 girls 9 years of age (Wolff 
et al. 2008a), BPA exposure was not associated 
with accelerated breast or pubic hair develop-
ment. In a study of 82 patients with pre  cocious 
puberty and 32 patients without pre  cocious 
puberty, BPA exposure was not associated 
with precocious puberty (Lee SH et al. 2014). 
However, in a study of 110 girls with preco-
cious puberty and 100 girls without precocious 
puberty, BPA was associated with increased 
uterine and ovarian volume (Qiao et al. 2010). 
These studies suggest that BPA exposure may 
not be associated with onset of puberty in girls, 
but given the limited number of studies, these 
results should be confirmed in future studies.
In animal models, the effects of BPA on 
factors such as puberty onset and sexual recep-
tivity are equivocal (see Supplemental Material, 
Table S8). In one study (Ryan et al. 2010), 
low-dose BPA did not affect the timing of 
puberty onset as measured by vaginal opening 
in LE rats orally exposed to BPA gestationally 
plus neo  natally. Conversely, low- and high-
dose BPA exposure accelerated vaginal opening 
in neo  natally exposed ICR mice (Nah et al. 
2011), SD rats (Fernández et al. 2009), and LE 
rats (Adewale et al. 2009). Low-dose BPA also 
decreased the time neonatally exposed ICR 
mice and SD rats spent in estrus (Fernández 
et al. 2009; Nah et al. 2011). However, low-
dose BPA did not affect estrous cyclicity in 
gestationally plus neo  natally exposed CD-1 
mice and LE rats (Adewale et al. 2009; Tyl 
et al. 2008). Further, low-dose BPA had no 
effect on lordosis behavior in gestationally plus 
neo  natally exposed LE rats (Ryan et al. 2010) 
or neo  natally exposed female LE rats (Adewale 
et al. 2009). Collectively, these studies indicate 
that the effects of BPA on the onset of puberty BPA and reproductive health
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and sexual receptivity in animal models are 
unclear and likely differ depending on strain 
and species. Further studies should exam-
ine differences in puberty onset and sexual 
receptivity in various strains and species of 
animal models.
Sexual Dysfunction
Few epidemiological or experimental   studies 
have examined the association between BPA 
exposure and sexual dysfunction. One cross-
sectional study of 425 men occupationally 
exposed to BPA reported an increased risk 
of self-reported impaired sexual abilities 
compared to 284 unexposed men (Li et al. 
2010) (see Supplemental Material, Table S6). 
Some animal studies have indicated that BPA 
may impair sexual ability (see Supplemental 
Material, Table S8). Low-dose BPA increased 
the time taken for copulation in neonatally or 
gestationally exposed Holtzman rats (Salian 
et al. 2009a, 2009b) and increased latency 
to insemination in perinatally exposed CF-1 
mice (deCatanzaro et al. 2013). Low-dose 
BPA also decreased intromission and ejacula-
tions of perinatally exposed male CF-1 mice 
mated to unexposed females (deCatanzaro 
et al. 2013). However, in another study, 
low- or high-dose BPA did not affect the 
time taken for copulation in gestationally plus 
neo  natally exposed adult CD-1 mice or their 
offspring (Tyl et al. 2008). Given the limited 
number of studies conducted on BPA and 
sexual function and the equivocal nature of 
the results, it is not possible to make firm con-
clusions on the effects of BPA on sexual func-
tion. However, it is important to note that all 
but one study conducted to date suggest that 
BPA negatively impacts sexual function.
Conclusions
Here we summarized the strength of the 
evidence for associations between BPA and 
adverse reproductive outcomes based on litera-
ture published from 2007 through 2013. 
The data presented in this review build on 
the overall conclusions of the expert panel 
report (vom Saal et al. 2007) that the wide-
spread effects of BPA in experi  mental animal 
studies are a concern for overall human health 
and may be involved in human reproduc-
tive disease. Similar to the 2007 expert panel 
report, we considered the evidence to be strong 
when multiple studies in multiple species indi-
cated a similar effect of BPA on a reproductive 
tissue or end point, even if concordance was 
not 100% across all studies, given that species 
and strain differences can lead to differences in 
dose response and magnitude of effect. These 
conclusions, however, are not to be consid-
ered definitive without further investigation, 
especially with the gaps in clear results detailed 
throughout the review. In the experimental 
studies, strong, definitive conclusions often 
were difficult because study designs were so 
different. Experimental studies rarely used 
the same doses, timing, positive controls, and 
exposure routes; thus, the effects of BPA on 
exposure among animal strains and species 
could not effectively be compared. However, 
one unifying strength of these studies related 
to human health is that most of the studies we 
evaluated used BPA doses below the LOAEL. 
In the epidemiological studies, strong conclu-
sions were difficult to determine because of 
study design and exposure parameters. For 
example, exposure assessments in most human 
studies relied on a single urine sample, which 
may introduce exposure misclassification and 
attenuate associations if they are present. Given 
the continuous and variable exposure to BPA, 
a single urine sample may not represent longer-
term exposure or exposure in the relevant etio-
logical window. Finally, most of the human 
studies were cross-sectional, making it difficult 
to discern the temporal relationship of expo-
sure with response. These limitations affect 
the interpretation of human studies. Future 
human studies need to consider improvements 
in exposure assessment to represent longer-
term BPA exposure assessed at etiologically 
relevant windows. Given recent data, it will be 
critical in future studies to assess effects of dif-
ferent routes of exposure and to analyze effects 
at different stages in the life of the exposed 
individual. In addition, for experi  mental 
studies, the inclusion of positive controls 
should be considered essential.
However, given the data included in 
this review, we have drawn some insights 
and conclusions that add to the conclusions 
drawn based on reviews of the BPA literature 
prior to 2007, categorized by the strength of 
evidence presented.
1. Strong evidence exists that
• BPA is an ovarian toxicant in animal 
models and women. It adversely affects 
the onset of meiosis in ovaries from both 
animal models and humans, interferes 
with germ cell nest breakdown in animal 
models, accelerates follicle transition in 
several animal species, alters steroido-
genesis in multiple animal models and 
in women, and reduces oocyte qual-
ity in animal models and in women 
undergoing IVF.
• BPA is a uterine toxicant in animal 
models because it impairs uterine 
endometrial cellular proliferation, 
decreases uterine receptivity, alters gene 
expression, and increases implanta-
tion failure in several strains and spe-
cies. However, human studies have not 
adequately addressed these end points.
• BPA is a prostate toxicant in animal 
models, impairing the steroido  genic 
capacity and altering dorsal and ventral 
lobe morphology, potentially leading to 
prostate pathogenesis. Human studies, 
however, are lacking.
• The effects of BPA on the reproductive 
system are variable and evident at doses 
below the LOAEL of 50 mg/kg and the 
proposed safe level of 50 μg/kg/day.
2. Limited evidence exists that
• Relative to the impact of BPA on birth 
rate, birth weight, and length of gesta-
tion, human data on birth weight are 
inconsistent; although animal studies 
suggest such an association, there are 
limited human studies on gestational 
length and pre  term birth.
• BPA exposure is associated with hyper-
androgenism, such as in PCOS in 
women. However, data in rodent models 
do not support the development of 
symptoms of human PCOS. 
• BPA is a testicular toxicant in animal 
models because it decreases sperm 
quality and motility, causes oxidative 
stress, and alters steroidogenesis. Human 
data, however, are inconsistent.
• BPA is associated with impaired implan-
tation in women undergoing IVF. The 
associations between BPA and implanta-
tion failure in women may be due to 
the effects of BPA on the embryo or the 
uterus, or both.
• BPA exposure in male rats is associated 
with implantation failure in non  exposed 
female rats. Human data, however, 
are lacking.
• BPA is associated with sexual dys  function 
among men exposed to high occupa-
tional levels and in experimental 
studies on males.
3. There is insufficient evidence to draw 
conclusions regarding effects of BPA 
on the oviduct, placenta, and pubertal 
development.
4. Future studies need to
• Consider the critical period of differen-
tiation of the organ system in question 
and the reproductive life span of the 
animal model or human.
• Use continuous exposure to BPA in 
view of the ubiquitous and continuous 
exposure to BPA in humans.
• Target internal dose levels of BPA that 
are achieved by human exposures.
• Recognize the potential interaction of 
BPA with other hormone-altering 
chemicals and lifestyle factors such as diet 
and stress.
• Distinguish organizational (perma-
nent) versus activational (transient) 
effects of BPA.
• Determine whether preterm and mater-
nal morbidities (e.g., preeclampsia, 
gestational diabetes), as well as paternal 
factors, modify or mediate the effects of 
BPA on the reproductive system.Peretz et al.
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